Virobay
2006 – Founded as a protease inhibitor drug discovery and development company
2007 – Filed IND and initiated Phase I trial with lead protease inhibitor as an oral treatment for Hepatitis C
2007 – In-licensed cathepsin protease inhibitor assets; including VBY-129, a selective cathepsin S inhibitor which completed phase 1 clinical development
2008 – Virobay assets solve the chemical challenge of cathepsin inhibitor design; multiple orally bioavailable development candidates are poised for Phase I
2010 – Virobay closes Series B financing
Contact Us
Virobay Inc.
1490 O’Brien Drive, Suite G
Menlo Park, CA 94025
Tel:
Fax:
Email:
Directions to Virobay
From San Francisco airport
Take 101 South (17 miles)
Exit on Willow Road East (~0.6 miles)
Turn right into O’Brien Drive (0.6 miles)
1490 is the second to last building on the right;
we are in Suite G access through the center door
From San Jose airport
Take 101 north (15 miles)
Exit on Willow Road East (~0.6 miles)
Turn right into O’Brien Drive (0.6 miles)
1490 is the second to last building on the right;
we are in Suite G access through the center door